Global Trial in APG2575 for Patients With CLL/SLL
Public ClinicalTrials.gov record NCT06104566. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Global Multicenter, Open Label, Randomized Phase 3 Registrational Study of Lisaftoclax (APG-2575) in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (GLORA Study)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a global multicenter, open label, randomized, registrational phase III study to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients who previously treated with BTK inhibitors
Study identification
- NCT ID
- NCT06104566
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 400 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 99 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 19, 2023
- Primary completion
- Dec 30, 2026
- Completion
- Oct 30, 2027
- Last update posted
- Jun 17, 2026
2023 – 2027
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ascentage Investigative Site | Tuscon | Arizona | 85742 | Recruiting |
| Ascentage Investigative Site | Anaheim | California | 92805 | Recruiting |
| Ascentage Investigative Site | Jacksonville | Florida | 32224 | Recruiting |
| Ascentage Investigative Site | Miami Beach | Florida | 33140 | Recruiting |
| Ascentage Investigative Site | Peoria | Illinois | 61615 | Recruiting |
| Ascentage Investigative Site | Boston | Massachusetts | 02215 | Recruiting |
| Ascentage Investigative Site | Ann Arbor | Michigan | 48109 | Recruiting |
| Ascentage Investigative Site | Greenville | North Carolina | 27834 | Recruiting |
| Ascentage Investigative Site | Houston | Texas | 77030 | Recruiting |
| Ascentage Investigative Site | Kingswood | Texas | 77339 | Recruiting |
| Ascentage Investigative Site | Richmond | Virginia | 23298 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 124 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06104566, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2026 · Synced Sep 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06104566 live on ClinicalTrials.gov.